BASILEA PHARMACEUTICALS
DEAD

Serial Number

86761593

Owner

Basilea Pharmaceutica AG

Attorney

Evan A. Raynes

Filing Date

Sep 18, 2015

Add to watchlist:

No watchlists yet
View on USPTO

BASILEA PHARMACEUTICALS Trademark

Serial Number: 86761593

BASILEA PHARMACEUTICALS is a trademark filed by Basilea Pharmaceutica AG on September 18, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Basilea Pharmaceutica AG (44 trademarks)

Grenzacherstrasse 487
CH-4005 Basel , CH

Entity Type: 99

Trademark Details

Filing Date

September 18, 2015

Registration Date

Not Registered

Published for Opposition

February 16, 2016

Goods & Services

Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; all of the aforesaid for prescription only

Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use

Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 13, 2019 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 13, 2019 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 28, 2018 EXRA
SOU EXTENSION 5 GRANTED
Sep 27, 2018 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 27, 2018 AITU
SOU EXTENSION 5 FILED
Sep 20, 2018 EXT5
SOU TEAS EXTENSION RECEIVED
Sep 20, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 21, 2018 EXRA
SOU EXTENSION 4 GRANTED
Mar 19, 2018 EX4G
SOU EXTENSION 4 FILED
Mar 19, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 19, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 26, 2017 EXRA
SOU EXTENSION 3 GRANTED
Sep 23, 2017 EX3G
SOU EXTENSION 3 FILED
Sep 23, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 23, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 29, 2017 EXRA
SOU EXTENSION 2 GRANTED
Mar 27, 2017 EX2G
SOU EXTENSION 2 FILED
Mar 27, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 27, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 11, 2016 EXRA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 7, 2016 TCCA
SOU EXTENSION 1 GRANTED
Oct 7, 2016 EX1G
SOU EXTENSION 1 FILED
Oct 7, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 7, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 12, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 16, 2016 NPUB
PUBLISHED FOR OPPOSITION
Feb 16, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 27, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 6, 2016 CNSA
ASSIGNED TO EXAMINER
Jan 5, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2015 NWOS
NEW APPLICATION ENTERED
Sep 22, 2015 NWAP